Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on Think Bioscience — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Think Bioscience raises $55 million in a Series A round led by Regeneron Ventures and others to develop drug discovery platforms.
Amount Raised
$55 Million
Round Type
series a
BoulderInvestors
Description
CE-Ventures announced its participation in the Series A funding round for Think Bioscience. The $55 million round was led by Regeneron Ventures, Innovation Endeavors, and Janus Henderson Investors. This capital will support the advancement of Think Bio’s small-molecule pipeline. Think Bioscience is focused on drug discovery for historically challenging disease targets.
Funding Insights
Based on industry dataWatching Think Bioscience? See every signal — funding, hires, M&A, contracts, sentiment.
See plans